Skip to main content

Francis Richard D

In the past year, 5 open-market sale filings worth $31.3M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$31.3M
5 filings
Net
−$31.3M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Francis Richard D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TEVA Teva Pharmaceutical Industries Ltd

President and CEO10 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 8, 2026 (view filing)Jun 53 daysFrancis Richard DPresident and CEOSSale−6.15K$34.35−$211.4K−0.5%1.18M after10b5-1
Mar 9, 2026 (view filing)Mar 54 daysFrancis Richard DPresident and CEOSSale−20.0K$31.67−$634.2K−1.7%1.17M after10b5-1
Mar 6, 2026 (view filing)Mar 42 daysFrancis Richard DPresident and CEOSSale−23.4K$32.46−$759.3K−2.0%1.15M after10b5-1
Mar 5, 2026 (view filing)Mar 32 daysFrancis Richard DPresident and CEOSSale−442.9K$32.36−$14.3M−28.3%1.12M after2 lots10b5-1
Feb 18, 2026 (view filing)Feb 153 daysFrancis Richard DPresident and CEOSSale−447.8K$34.22−$15.3M−42.5%605.8K after2 lots10b5-1
Mar 6, 2025 (view filing)Mar 4-52 daysFrancis Richard DPresident and CEOSSale−23.8K$15.79−$375.4K−8.0%271.8K after2 lots10b5-1
Mar 5, 2025 (view filing)Mar 3-42 daysFrancis Richard DPresident and CEOSSale−31.3K$16.06−$503.4K−11.3%245.3K after2 lots10b5-1
Feb 19, 2025 (view filing)Feb 181 dayFrancis Richard DPresident and CEOSSale−75.5K$16.95−$1.28M−26.5%209.4K after10b5-1
Mar 5, 2024 (view filing)Mar 41 dayFrancis Richard DPresident and CEOSSale−31.1K$13.34−$414.4K−20.1%123.3K after10b5-1
Feb 20, 2024 (view filing)Feb 155 daysFrancis Richard DPresident and CEOSSale−74.5K$13.15−$980.1K−46.1%87.1K after10b5-1